Headline should read Bronstein, Gewirtz & Grossman, LLC Investigates Integra LifeSciences Holdings Corp. (sted Bronstein, Gewirtz & Grossman, LLC Investigates LifeSciences Holdings Corp.)
The corrected release reads:
BRONSTEIN, GEWIRTZ & GROSSMAN, LLC INVESTIGATES INTEGRA LIFESCIENCES HOLDINGS CORP.
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Integra LifeSciences Holdings, Corp. (“Integra” or the “Company”) (NASDAQ:IART), concerning whether the company and certain of its officers and directors have violated federal securities laws.On Friday, January 6, 2012, shares of Integra, a maker of orthopedic implants, fell $6.01 or almost 20% to close at $24.49 after cutting its revenue forecast and saying U.S. regulators cited the company for mold at a factory. In addition, Integra recently received a warning letter from the US Food and Drug Administration (“FDA”) pertaining to quality systems and compliance issues at its collagen manufacturing facility in Plainsboro, New Jersey. Earlier in August, the company received a Form 483 observation from the FDA regarding manufacturing concerns at this collagen manufacturing facility. Collagen products currently represent roughly 23% of total sales and are manufactured at two facilities (the second in Puerto Rico). If you are aware of any facts relating to this investigation, or purchased shares of Integra, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email firstname.lastname@example.org. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate work, private securities offerings, and securities arbitration.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV